Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 137 of the 138 references it cites were found in a registry or an index.

Autosomal dominant polycystic kidney disease

Cornec-Le Gall, Emilie, Alam, Ahsan, Perrone, Ronald D · 2019 · The Lancet

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and one of the most common causes of end-stage kidney disease. Multiple clinical manifestations, such as enlarged kidneys filled with growing cysts, hypertension, and multiple extrarenal complications, including liver cysts, intracranial aneurysms, and cardiac valvular disease, show that ADPKD is a systemic disorder. New information derived from clinical research using molecular genetics and advanced imaging techniques has provided enhanced tools for assessing the diagnosis and prognosis for individual patients and their families. Phase 3 randomised, placebo-controlled clinical trials have clarified aspects of disease management and a disease-modifying therapeutic drug is now available for patients with high risk of rapid disease progression. These developments provide a strong basis on which to make clear recommendations about the management of affected patients and families. Implementation of these advances has the potential to delay kidney failure, reduce the symptom burden, lessen the risk of cardiovascular complications, and prolong life.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(18)32782-x

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 138 references

Research works printed but not linked: 4

  1. Cornec-Le Gall, 2016, Determinants of disease variability in ADPKD: insights from a cohort of 1634 PKD1 patients, J Am Soc Nephrol, 27, 766A
  2. Hogan, 2016, Randomized, placebo controlled double blind clinical trial of the somatostatin analog pasireotide LAR for patients with ADPKD or ADPLD with severe liver involvement, J Am Soc Nephrol, 27, 34A
  3. Chebib, 2018, A practical guide for treatment of rapidly progressive ADPKD with tolvaptan, J Am Soc Nephrol, 29, 2458, 10.1681/asn.2018060590 · DOI · Paper page
  4. Hogan, 2010, Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease, J Am Soc Nephrol, 21, 1052, 10.1681/asn.2009121291 · DOI · Paper page

Cited by

See all 674

Metadata

Authors
Cornec-Le Gall, E., Alam, A., & Perrone, R. D.
Affiliations
  • McGill University Health Centre (CA)
  • Tufts Medical Center (US)
Corresponding author
Perrone, Ronald D
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-03
Volume
393
Issue
10174
Pages
919-935
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W3152017609
Cited by
624
References
138
Citations by year
2026: 83 · 2025: 108 · 2024: 86 · 2023: 109 · 2022: 88 · 2021: 76 · 2020: 57 · 2019: 13
FWCI
7.75
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Keywords
autosomal dominant polycystic kidney disease, hereditary kidney disease, end-stage renal disease, renal cysts, hypertension, liver cysts, intracranial aneurysm, valvular heart disease, molecular genetics, diagnostic imaging, prognosis, disease-modifying therapy, disease progression, cardiovascular complications, clinical management
MeSH terms
Adult, Aged, Cysts, Female, Genetic Testing, Humans, Liver Diseases, Magnetic Resonance Imaging, Male, Middle Aged, Mutation, Ultrasonography, Randomized Controlled Trials as Topic, Polycystic Kidney, Autosomal Dominant, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autosomal dominant polycystic kidney disease. https://app.cochat.ai/papers/10.1016/s0140-6736(18)32782-x
The paper
Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019). Autosomal dominant polycystic kidney disease. The Lancet. https://doi.org/10.1016/s0140-6736(18)32782-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.